- American City Business Journals•6 days ago
The Washington region's 10 biggest publicly traded biotech companies saw their stock prices dip Wednesday after President-elect Donald Trump said, in his first press conference in his new role, that the ...
- GlobeNewswire•12 days ago
ROCKVILLE, MD, Jan. 05, 2017--. MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of ...
MGNX : Summary for MacroGenics, Inc. - Yahoo Finance
MacroGenics, Inc. (MGNX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||19.07 - 19.91|
|52 Week Range||14.84 - 33.30|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-12.81|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|